SARAN ATUL
Insider CIK 1591070 · MGNX Sr. VP and General Counsel · XNCR Director · EBS EVP, Corp Dev, GC & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 971 | $12.38 | $12.0K | 86,645 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-24 | 2023-02-27 | 845 | $13.71 | $11.6K | 87,616 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-23 | 2023-02-27 | 365 | $14.30 | $5.2K | 88,461 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2023-02-08 | 2023-02-10 | 2,051 | $13.25 | $27.2K | 88,826 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-02-08 | 2023-02-10 | 95 | — | $0 | 90,877 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2022-03-01 | 2022-03-02 | 38,664 | $41.38 | $1.60M | 38,664 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-03-01 | 2022-03-02 | 16,916 | — | $0 | 91,546 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-03-01 | 2022-03-02 | 31,417 | — | $0 | 74,630 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-28 | 2022-03-02 | 764 | $39.64 | $30.3K | 90,782 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-24 | 2022-02-25 | 857 | $42.47 | $36.4K | 43,213 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-23 | 2022-02-25 | 442 | $42.23 | $18.7K | 44,070 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-02-22 | 2022-02-24 | 1,836 | — | $0 | 46,596 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2022-02-22 | 2022-02-24 | 2,084 | $42.23 | $88.0K | 44,512 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-26 | 2021-02-26 | 799 | $97.15 | $77.6K | 44,760 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-26 | 2021-02-26 | 764 | $97.15 | $74.2K | 45,559 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2021-02-24 | 2021-02-26 | 14,973 | $93.49 | $1.40M | 14,973 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-24 | 2021-02-26 | 3,744 | — | $0 | 47,210 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-24 | 2021-02-26 | 887 | $93.49 | $82.9K | 46,323 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-24 | 2021-02-26 | 3,744 | — | $0 | 43,466 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-09 | 2021-02-11 | 2,656 | — | $0 | 42,152 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-02-09 | 2021-02-11 | 2,430 | $123.45 | $300.0K | 39,722 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-08-07 | 2020-08-11 | 1,303 | $126.96 | $165.4K | 39,496 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-02-26 | 2020-02-27 | 508 | $59.91 | $30.4K | 41,381 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-02-26 | 2020-02-27 | 582 | $59.91 | $34.9K | 40,799 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 22,784 | $61.44 | $1.40M | 43,105 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2020-02-25 | 2020-02-27 | 5,697 | — | $0 | 41,889 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2020-02-25 | 2020-02-27 | 5,697 | — | $0 | 36,192 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-08-07 | 2019-08-09 | 1,287 | $44.47 | $57.2K | 30,495 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2019-02-26 | 2019-02-28 | 20,321 | $61.01 | $1.24M | 20,321 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2019-02-26 | 2019-02-28 | 5,081 | — | $0 | 26,701 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2019-02-26 | 2019-02-28 | 5,081 | — | $0 | 31,782 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-26 | 2019-02-28 | 534 | $61.01 | $32.6K | 21,620 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-08-07 | 2018-08-09 | 1,286 | $54.65 | $70.3K | 22,154 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2018-02-27 | 2018-03-01 | 21,253 | $49.64 | $1.05M | 21,253 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-02-27 | 2018-03-01 | 5,313 | — | $0 | 23,440 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-02-27 | 2018-03-01 | 5,313 | — | $0 | 18,127 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2017-08-08 | 2017-08-10 | 20,083 | — | $0 | 20,083 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2017-08-08 | 2017-08-10 | 12,814 | — | $0 | 12,814 | SEC↗ |
| MGNX MACROGENICS INC | F Tax w/h | 2017-04-28 | 2017-05-02 | 1,862 | $21.61 | $40.2K | 16,986 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2017-02-15 | 2017-02-16 | 55,000 | $20.53 | $1.13M | 55,000 | SEC↗ |
| MGNX MACROGENICS INC | F Tax w/h | 2016-04-28 | 2016-04-29 | 1,730 | $20.84 | $36.1K | 18,980 | SEC↗ |
| MGNX MACROGENICS INC | F Tax w/h | 2016-04-28 | 2016-06-01 | 1,862 | $20.84 | $38.8K | 18,848 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2015-12-18 | 2015-12-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MGNX MACROGENICS INC | F Tax w/h | 2015-04-28 | 2015-04-29 | 925 | $32.02 | $29.6K | 20,710 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2014-12-12 | 2014-12-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MGNX MACROGENICS INC | F Tax w/h | 2014-10-28 | 2014-10-30 | 865 | $21.79 | $18.8K | 21,635 | SEC↗ |
| XNCR Xencor Inc | C Conversion deriv | 2013-12-06 | 2013-12-06 | 4,090,519 | — | $0 | 0 | SEC↗ |
| XNCR Xencor Inc | C Conversion | 2013-12-06 | 2013-12-06 | 1,319,522 | — | $0 | 1,319,522 | SEC↗ |